The law firm, which specializes in securities litigation and corporate malfeasance, is currently soliciting feedback from stakeholders to assess potential legal recourse. Shareholders concerned about the impact of these board-level decisions are encouraged to contact lead attorney Robert H. Lefkowitz for a private consultation regarding their legal options. Further information regarding the scope of this investigation is available through the firm’s dedicated portal, where investors can review their rights in light of the ongoing internal scrutiny.
In section Releases
Purcell & Lefkowitz Launches Probe into Celldex Therapeutics Governance
New York-based Purcell & Lefkowitz LLP has initiated a formal investigation into Celldex Therapeutics, Inc., scrutinizing whether the company’s board of directors violated fiduciary obligations during recent corporate actions. The inquiry centers on potential misconduct that may have adversely impacted shareholder interests regarding the NASDAQ-listed firm.
Comments (0)
No comments yet. Be the first!